Sort
21,453 grants matching “tuberculosis”
Control of Bacterial Toxins by Viruses and Plasmids
$543,100Randall K Holmes · University Of Colorado Denver · R37 · FY2011 · AI
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
$543,018Awewura Jacob Kwara · Miriam Hospital · R01 · FY2014 · HD
Discovery of inhibitors that target the Mtb ClpP1P2 protease
$542,890Eric Joseph Rubin · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
DNA GYRASE AND QUINOLONE RESISTANCE IN TUBERCULOSIS
$542,882Public Health Research Institute · R01 · FY2000 · AI
BU Clinical HIV/AIDS Research Training Program (BU-CHART
$542,752Benjamin P Linas · Boston Medical Center · T32 · FY2024 · AI
INTERCEPT
$542,658Reinout Van Crevel · Stichting Radboud Universitair Medisch Centrum I.O. · R01 · FY2022 · AI
Subproject 1
$542,456David Eisenberg · Los Alamos Nat Secty-Los Alamos Nat Lab · U54 · FY2008 · GM
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$542,407Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study
$542,244Neil A Martinson · Wits Health Consortium (Pty), Ltd · R01 · FY2017 · AI
Subproject 1
$542,189David Eisenberg · Los Alamos Nat Secty-Los Alamos Nat Lab · U54 · FY2007 · GM
Clinical Core
$541,670Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2021 · AI
Modulation of Host Responses by Mycobacterium tuberculosis
$541,546Jyothi Rengarajan · Emory University · R56 · FY2016 · AI
Molecular and Cellular Immunology
$541,453Anthony L. Defranco · University Of California, San Francisco · T32 · FY2013 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis
$541,354Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2016 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$541,270Richard R Whitley · Nevada State Dept Of Hlth/Human Svcs · U52 · FY2008 · PS
URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherence
$541,238Judith Alissa Hahn · University Of California, San Francisco · U01 · FY2017 · AA
Administrative Core
$541,123Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2011 · AI
Perceived Immigration Laws and Infectious Disease Control Measures
$541,052Carol L Galletly · Medical College Of Wisconsin · R01 · FY2024 · NR
Chemical Mycobateriology
$541,003Carolyn R Bertozzi · Stanford University · R37 · FY2016 · AI
T regulatory cells and immunity in tuberculosis
$540,947Kevin B Urdahl · Seattle Biomedical Research Institute · R01 · FY2014 · AI
T regulatory cells and immunity in tuberculosis
$540,947Kevin B Urdahl · Seattle Biomedical Research Institute · R01 · FY2016 · AI
Fostering resilience to psychosocial and HIV risk in Indian MSM
$540,897Conall Michael O'Cleirigh · Massachusetts General Hospital · R01 · FY2016 · MH
N.J. MEDICAL SCHOOL GLOBAL TUBERCULOSIS INSTITUTE REGIONAL TRAINING & MEDICAL CON
$540,694Lee Reichman · Rbhs-New Jersey Medical School · U52 · FY2013 · PS
RNA modification and antibiotic resistance
$540,610Graeme L Conn · Emory University · R01 · FY2021 · AI
COMPREHENSIVE REAGENTS FOR IMMUNOPHENOTYPING RABBIT CELL-MEDIATED IMMUNITY.
$540,608Natalie Castellana · Digital Proteomics Llc · N43 · FY2020 · AI